1 / 37

Human herpesviruses

Human herpesviruses. Three subfamilies (genome structure, tissue tropism, cytopathologic effect, site of latent infection) Alphaherpesvirinae: Human herpesvirus 1 Herpes simplex type 1 HSV-1 Human herpesvirus 2 Herpes simplex type 2 HSV-2 Human herpesvirus 3 Varicella-zoster virus VZV

oprah-bass
Download Presentation

Human herpesviruses

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Human herpesviruses • Three subfamilies (genome structure, tissue tropism, cytopathologic effect, site of latent infection) • Alphaherpesvirinae: Human herpesvirus 1 Herpes simplex type 1 HSV-1 Human herpesvirus 2 Herpes simplex type 2 HSV-2 Human herpesvirus 3 Varicella-zoster virus VZV • Gammaherpesvirinae Human herpesvirus 4 Epstein-Barr virus EBV Oncogenic Human herpesvirus 8 Kaposi’s sarcoma related virus HHV-8 Oncogenic • Betaherpesvirinae Human herpesvirus 5 Cytomegalovirus CMV Congenital inf Human herpesvirus 6Herpes lymphotropic virus HHV-6 Human herpesvirus 7 Human herpesvirus 7 HHV-7

  2. Human herpesviruses • Large, enveloped double stranded DNA viruses • Icosahedral capsid • Sensitive to acid, solvents, detergents and drying

  3. Human herpesviruses They have common: • Virion morphology • Basic mode of replication • Capacity to establish latent and recurrent infections, in case of EBV immortalizing infections • Ubiquitous • Usually cause benign disease especially in children • In immunosuppressed people they cause significant morbidity and mortality

  4. Human herpesviruses -DNA polymerase: -viral DNA replication -good target for antiviral drugs. -DNA replication and assembly:nucleus -buds from nuclear membrane, released by exocytosis and cell lysis. -lytic,persistant, latent, for EBV immortalizing infections

  5. Herpes simplex virus • Two types: HSV-1 and HSV-2 • HSV can infect most types of human cells and even cells of other species. • Lytic infection of fibroblasts and epitelial cells but latent infection of neurons • The primary target cell: mucoepitelial cells • Site of latency: neurons

  6. Herpes simplex virus • Means of spread: HSV-1 close contact, HSV-2 close contact+sexual transmission! • Generally cause infection at the site of infection • HSV-1: infections above the waist • HSV-2: infections below the waist • Growth characteristics are different • HSV-2 :more potential for viremia

  7. Herpes simplex virus • Disease initiates by direct contact, depends on the infected tissue (oral, brain, genital) • Direct cytopathologic effect • Lytic infections of most cells, latent infection of neurons(hides from immune response) • Cell to cell spread-syncytia(avoids antibody) • Cowdry type A acidophilic intranuclear inclusion bodies

  8. Herpes simplex virus • Initiates infection through mucosal membranes or breaks in the skin • Virus replicates in the cells at the base of the lession and infects the innervating neurons • Travels by retrograde transport to the ganglion( trigeminal ganglion for oral HSV, sacral ganglia for genital HSV)

  9. Herpes simplex virus • Then turns to initial site of infection • May be inapparent or vesicular( vesicle fluid contains infectious virons) • Tissue damage: viral pathology+immunopathology • Heals without a scar • Latent infection occurs in neurons

  10. Herpes simplex virus • Recurrence: stress, trauma, fever, sunlight) • The virus travels back down the nerve causing lessions at the dermatome • Recurrences are less severe and more localized

  11. HSV-1 is common • 90% have antibody by 2 years of age • HSV-2 occurs later in life with sexual activity • Physicians,nurses,dentists at risk for infection of fingers (herpetic whitlow) • Immunocompromised people and neonates at risk of disseminated, life-threateneing disease.

  12. Laboratory diagnosis • Cytology and histology: Tzanck smear(scraping of the base of a lesion), Papanicolaou smear or biopsy specimen • Cytopathic effects: syncytia, ballooning of cytoplasm, Cowdry A intranuclear inclusions • Direct antigen detection: immunofluorescence method or immunoperoxidase method • DNA :in situ hybridization or PCR in tissue or vesicle fluid

  13. Laboratory diagnosis • Virus isolation: not routine now • Serology:primary infection, type specific antibody by ELISA (differentiates HSV-1 and HSV-2)

  14. Varicella-Zoster • Chickenpox(varicella) • With recurrence :herpes zoster-shingles:zona • Primary target cell: mucoepitelial cell • Site of latency: neuron • Means of spread: respiratory and close contact • Viremia occurs after local replication :skin lessions over the entire body

  15. Varicella-Zoster • Primary VZV infection: mucosa of respiratory tract • Viremia • Reticuloendotelial system,liver,spleen • 11-13 days later secondary viremia • Virus is spread through the body and skin=rash+fever+systemic symptoms

  16. Varicella-Zoster • Latent in dorsal root or cranial nerve ganglia after primary infection • Reactivates in older adults and in patients with impaired immunity. • On reactivation : a vezicular rash along the entire dermatome • Children and leukemia: VZV more serious and more disseminated disease

  17. Varicella-Zoster • Extremely communicable • Rates of infection exceeds 90% among household contact • Contagious before and during symptoms. • HZ develops in 10-20% of people infected with VZV and contains viable virus.

  18. Varicella-Zoster • Laboratory diagnosis: • Cytology • Virus isolation: difficult • NAT • Serology • Treatment: • ACV,famciclovir and valacyclovir • Prophylaxis: VZIG:varicella-zoster immunoglobulin:immunosuppressed patients • A live attenuated vaccine(Oka strain)

  19. Epstein-Barr Virus • Heterophile antibody-positive infectious mononucleosis • Chronic disease • Associated with endemic Burkitt’s lymphoma, Hodgkin’s disease, nasopharyngeal carcinoma, B-cell lymphomas in patients with acquired or congenital immunodeficiencies. • Hairy oral leukoplakia • Mitogen for B cells and immortalizes them

  20. Epstein-Barr Virus Gammaherpesvirinae: Primary target cell: B cells and epitelial cells Site of latency: B cell Means of spread: saliva (kissing disease) Limited host range and tissue tropism: receptor for C3d component of the complement system (CR2 or CD21) which is expressed on B cells of humans and some epitelial cells of oro- and nasopharynx.

  21. EBV-associated neoplasms • Geographic distribution • Co-factor? • Endemic Burkett’s lymphoma: Africa:malaria • Nasopharyngeal carcinoma: China

  22. Laboratory diagnosis • Heterophile antibody: results from nonspecific activation of B cells by EBV • IgM antibody recognizes Paul-Bunnell antigen on sheep, horse and bovine erythrocytes not on guinea pig kidney cells • Detected at the end of first week , lasts for several months • Monotest, ELISA: specific antibodies • VCA-IgM, antibody to early antigen (EA): recent infection • VCA-IgG, EBNA: previous infection • PCR

  23. Cytomegalovirus(CMV) • Betaherpesvirnae: lymphotropic • Primary target cell: monocyte, lymphocte, epitelial cell • Site of latency: monocyte, lymphocyte and? • Means of spread: close contact, transfusions, tissue transplant and congenital

  24. Clinical findings • Predominant presentation: asymptomatic • Neonates: deafness, mental retardation • Immunosuppressed patients: disseminated dissease, severe disease (pneumonia, retinitis, colitis, esophagitis)

  25. Congenital infection • An important cause of congenital disease • Serious birth defects is high if primary infection occurs during pregnancy • Microcephaly, intracerebral calcification,hepatosplenomegaly,rash(cytomegalic inclusion disease), unilateral or bilateral hearing loss, mental retardation • CMV in the urine in the first week (culture,PCR)

  26. Laboratory tests • Cytology and histology: ‘OWL’s eye’ inclusion body basophilic intranuclear:Urine not so sensitive • Antigen in peripheral leucocytes • DNA by PCR • Cell culture: Human diploid fibroblasts • Serology: primary infection(IgM by ELISA)

  27. Human herpesvirus 6 • Betaherpesvirinae • Lymphotropic , ubiquitous • Primary target cell: T cells and ? • Site of latency: T cells and ? • Means of spread: Respiratory, close contact • Exanthema subitum: roseola • A mononucleosis syndrome and lympadenopathy

  28. Human herpesvirus 8 • HHV-8 DNA sequences were discovered by PCR in biopsy specimens of • Kaposi’s sarcoma (characteristic opportunistic diseases associated with AIDS) • Primary effusion lymphoma (rare type of B-cell lymphoma) • Multicentric Castleman’s disease

  29. Human herpesvirus 8 • Kaposi’s sarcoma-related virus • Primary target cell: Lymphocyte and other cells • Site of latency:? • Means of spread: close contact, sexual, saliva? • Limited to certain geographic areas (Italy, Greece, Africa) and AIDS

  30. Human herpesvirus 8 • Laboratory diagnosis: • Serology: specific antibodies:IFA IgG,IgM • HHV-8 DNA by PCR

  31. Antivirals Herpes Simplex 1 and 2 Acyclovir Penciclovir Valacyclovir Famciclovir Adenosine arabinoside (ara-A) Trifluridine

  32. Antivirals Varicella-Zoster Virus Acyclovir Famciclovir Valacyclovir Varicella-zoster immune globulin (VZIG) Zoster immune plasma Live vaccine Epstein-Barr Virus None

  33. Antivirals Cytomegalovirus Ganciclovir* Valganciclovir* Iododeoxyuridine Foscarnet* Trifluridine Cidofovir*

  34. Herpesvirus simiae(B virus) • Asian monkeys • Bites, saliva • Encephalopathy in humans • fatal

More Related